Study on multidrug resistance mechanism and reversal strategy of hepatocellular carcinoma based on exosome

Zhigang Zhang, L. Fang
{"title":"Study on multidrug resistance mechanism and reversal strategy of hepatocellular carcinoma based on exosome","authors":"Zhigang Zhang, L. Fang","doi":"10.25236/FMSR.2021.030405","DOIUrl":null,"url":null,"abstract":"MDR (multidrug resistance) refers to the phenomenon that after tumor cells develop resistance to a chemotherapeutic drug, they also develop cross-resistance to other chemotherapeutic drugs with different chemical structures and mechanisms. HCC (Hepatocellular carcinoma) is the fourth most common cause of cancer-related deaths in the world. Exosomes, produced by polyhedra, are extracellular lipid nano-vesicles with various bioactive substances, which contain lipid RNA, DNA and protein. Exosomes produced by tumor cells carry important information about tumor cells. Studies have found that non-coding RNAs, as an important part of exosomes, are involved in the regulation of the tumor microenvironment of HCC, including tumorigenesis, tumor metastasis, angiogenesis, immune regulation and other processes, and play an important role in the diagnosis, treatment and prognosis of tumors. Therefore, studying the molecular mechanism of MDR and exploring the reversal strategy is a hot topic in tumor research at present. This paper reviews the research progress in this field.","PeriodicalId":129141,"journal":{"name":"Frontiers in Medical Science Research","volume":"89 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2021-08-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in Medical Science Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.25236/FMSR.2021.030405","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

MDR (multidrug resistance) refers to the phenomenon that after tumor cells develop resistance to a chemotherapeutic drug, they also develop cross-resistance to other chemotherapeutic drugs with different chemical structures and mechanisms. HCC (Hepatocellular carcinoma) is the fourth most common cause of cancer-related deaths in the world. Exosomes, produced by polyhedra, are extracellular lipid nano-vesicles with various bioactive substances, which contain lipid RNA, DNA and protein. Exosomes produced by tumor cells carry important information about tumor cells. Studies have found that non-coding RNAs, as an important part of exosomes, are involved in the regulation of the tumor microenvironment of HCC, including tumorigenesis, tumor metastasis, angiogenesis, immune regulation and other processes, and play an important role in the diagnosis, treatment and prognosis of tumors. Therefore, studying the molecular mechanism of MDR and exploring the reversal strategy is a hot topic in tumor research at present. This paper reviews the research progress in this field.
基于外泌体的肝癌多药耐药机制及逆转策略研究
多药耐药(MDR)是指肿瘤细胞在对一种化疗药物产生耐药性后,对其他化学结构和机制不同的化疗药物产生交叉耐药的现象。HCC(肝细胞癌)是世界上癌症相关死亡的第四大常见原因。外泌体是由多面体产生的细胞外脂质纳米囊泡,含有多种生物活性物质,包括脂质RNA、DNA和蛋白质。肿瘤细胞产生的外泌体携带肿瘤细胞的重要信息。研究发现,非编码rna作为外泌体的重要组成部分,参与肝癌肿瘤微环境的调控,包括肿瘤发生、肿瘤转移、血管生成、免疫调节等过程,在肿瘤的诊断、治疗和预后中发挥重要作用。因此,研究MDR的分子机制并探索其逆转策略是当前肿瘤研究的热点。本文综述了该领域的研究进展。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信